Directory
>
Philip Wills
Philip Wills
Chief Commercial Officer, Cell & Gene Therapy | Catalent
Maryland, Baltimore, United States
Philip Wills
Summary
Philip Wills is an accomplished Chief Commercial Officer specializing in Cell & Gene Therapy, with a robust background in commercial strategy and pharmacology. He currently leads initiatives at Catalent, a global leader in advanced therapies, where he has been instrumental since May 2019. Philip holds a PhD in Pharmacology from the University of Maryland Baltimore and a BA in Chemistry from Johns Hopkins University, showcasing his strong academic foundation in the life sciences. His expertise in navigating complex commercial landscapes in biotechnology positions him as a key player in the industry. Philip's leadership experience at a major organization like Catalent reflects his ability to drive growth and innovation in a rapidly evolving field. He is passionate about the intersection of science and business, particularly in the development of transformative therapies. His career trajectory demonstrates a commitment to excellence and a deep understanding of the commercial dynamics within the healthcare sector.
Philip Wills
Work Experience
Chief Commercial Officer, Cell & Gene Therapy at
Catalent
May 2019 - Present
Philip Wills
Education
University of Maryland Baltimore, PhD, Pharmacology
Johns Hopkins University, BA, Chemistry
Frequently Asked Questions about Philip Wills
What is Philip Wills email address?
Philip Wills's primary email address is ************@catalent.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Philip Wills work for?
Philip Wills is a Chief Commercial Officer, Cell & Gene Therapy at Catalent.
Where Philip Wills graduated from?
Philip Wills holds a degree in null from University of Maryland Baltimore.
How can I directly contact Philip Wills?
To contact Philip Wills directly, you can use the email address ************@catalent.com. Complete contact information is available upon registration with Muraena.
Who is Philip Wills?
Philip Wills is an accomplished Chief Commercial Officer specializing in Cell & Gene Therapy, with a robust background in commercial strategy and pharmacology. He currently leads initiatives at Catalent, a global leader in advanced therapies, where he has been instrumental since May 2019. Philip holds a PhD in Pharmacology from the University of Maryland Baltimore and a BA in Chemistry from Johns Hopkins University, showcasing his strong academic foundation in the life sciences. His expertise in navigating complex commercial landscapes in biotechnology positions him as a key player in the industry. Philip's leadership experience at a major organization like Catalent reflects his ability to drive growth and innovation in a rapidly evolving field. He is passionate about the intersection of science and business, particularly in the development of transformative therapies. His career trajectory demonstrates a commitment to excellence and a deep understanding of the commercial dynamics within the healthcare sector.
Philip`s contact details
************@catalent.com
Colleagues
Regulatory Affairs Manager
Wissenschaftlicher Mitarbeiter am Lehrstuhl für Controlling und Organisation
VP Finance
Operations Planning - AMPS / TDMA Specialist
VP Commercial BD
Manufacturing
Technical Services Manager
Associate Director, Human Resources
Associate Product Manager - Marketing | International | Campaign Execution
Vice President Regulatory Compliance